{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:27:23Z","timestamp":1774956443717,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["seminperinat.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.semperi.2014.03.008","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T07:25:00Z","timestamp":1400138700000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Second- and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease"],"prefix":"10.1053","volume":"38","author":[{"given":"Zeynep Alpay","family":"Savasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray O.","family":"Bahado-Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2014.03.008_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejogrb.2011.07.025","article-title":"Ischemic placental disease: epidemiology and risk factors","volume":"159","author":"Ananth","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1053\/j.semperi.2014.03.008_bib2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"Society for maternal\u2013fetal medicine First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9378(97)70512-X","article-title":"The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia","volume":"176","author":"Ashour","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0029-7844(97)00088-4","article-title":"The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein","volume":"89","author":"Morssink","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0002-9378(91)90525-V","article-title":"Does unexplained second-trimester (15 to 20 weeks\u2019 gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein","volume":"164","author":"Simpson","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1067\/mob.2000.103890","article-title":"Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?","volume":"182","author":"Stamilio","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","article-title":"Quad screen as a predictor of adverse pregnancy outcome","volume":"106","author":"Dugoff","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/pd.1654","article-title":"Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption","volume":"27","author":"Tikkanen","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/uog.7308","article-title":"Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A","volume":"34","author":"Proctor","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"303","key":"10.1053\/j.semperi.2014.03.008_bib10","first-page":"e1","article-title":"Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay","volume":"208","author":"Spaggiari","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"228","key":"10.1053\/j.semperi.2014.03.008_bib11","first-page":"e1","article-title":"Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia","volume":"207","author":"Olsen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/plac.2000.0540","article-title":"Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia","volume":"21","author":"Aquilina","year":"2000","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0029-7844(96)00310-9","article-title":"The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications","volume":"88","author":"Waller","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000322742","article-title":"Early detection of preeclampsia using inhibin a and other second-trimester serum markers","volume":"29","author":"Ree","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.008_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0029-7844(97)00677-7","article-title":"Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome","volume":"91","author":"Kowalczyk","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2006-947724","article-title":"Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction","volume":"23","author":"Odibo","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1053\/j.semperi.2014.03.008_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","article-title":"Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome","volume":"181","author":"Yaron","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib18","article-title":"Prediction of obstetrical risk using maternal serum markers and clinical risk factors","author":"Metcalfe","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.placenta.2011.01.018","article-title":"Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A","volume":"32","author":"Fitzgerald","year":"2011","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/jms.2012.011085","article-title":"The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia","volume":"19","author":"Bestwick","year":"2012","journal-title":"J Med Screen"},{"key":"10.1053\/j.semperi.2014.03.008_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-0032-1331025","article-title":"Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening","volume":"30","author":"Boucoiran","year":"2013","journal-title":"Am J Perinatol"},{"key":"10.1053\/j.semperi.2014.03.008_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1701-2163(16)35157-X","article-title":"Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review","volume":"34","author":"Hui","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1053\/j.semperi.2014.03.008_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/HJH.0b013e328357c0c9","article-title":"Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia","volume":"30","author":"Leanos-Miranda","year":"2012","journal-title":"J Hypertens"},{"issue":"suppl","key":"10.1053\/j.semperi.2014.03.008_bib25","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.placenta.2011.11.021","article-title":"Review: biochemical markers to predict preeclampsia","volume":"33","author":"Anderson","year":"2012","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0029-7844(01)01341-2","article-title":"Decreased maternal serum placenta growth factor in early second trimester and preeclampsia","volume":"97","author":"Su","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00404-012-2662-2","article-title":"Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?","volume":"287","author":"Ghosh","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1053\/j.semperi.2014.03.008_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.2217","article-title":"Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia","volume":"29","author":"Lim","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/pd.2065","article-title":"Circulating soluble endoglin and placental abruption","volume":"28","author":"Signore","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pd.1869","article-title":"Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption","volume":"27","author":"Tikkanen","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib31","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/pd.2387","article-title":"Early onset preeclampsia and second trimester serum markers","volume":"29","author":"Lambert-Messerlian","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"175","key":"10.1053\/j.semperi.2014.03.008_bib35","first-page":"e1","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/uog.8800","article-title":"activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia","volume":"37","author":"Yu","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0002-9378(99)70606-X","article-title":"Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies","volume":"180","author":"Silver","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0143-4004(95)90102-7","article-title":"Hypertension in pregnancy: changes in activin A maternal serum concentration","volume":"16","author":"Petraglia","year":"1995","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib39","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(96)09264-1","article-title":"Activin A and inhibin A as possible endocrine markers for pre-eclampsia","volume":"349","author":"Muttukrishna","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.semperi.2014.03.008_bib40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0029-7844(00)00926-1","article-title":"Serum levels of activin A and inhibin A and the subsequent development of preeclampsia","volume":"96","author":"Grobman","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib41","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-0528.2008.01902.x","article-title":"Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study","volume":"115","author":"Gonen","year":"2008","journal-title":"BJOG"},{"key":"10.1053\/j.semperi.2014.03.008_bib42","doi-asserted-by":"crossref","first-page":"263871","DOI":"10.5402\/2012\/263871","article-title":"PP13 and PAPP-A in the first and second trimesters: predictive factors for preeclampsia?","volume":"2012","author":"Moslemi Zadeh","year":"2012","journal-title":"ISRN Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/01443615.2012.709290","article-title":"Biomarkers in pre-eclampsia: a novel approach to early detection of the disease","volume":"32","author":"Masoura","year":"2012","journal-title":"J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/j.1600-0412.2004.00277.x","article-title":"Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies","volume":"83","author":"Bersinger","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1053\/j.semperi.2014.03.008_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/plac.2002.0828","article-title":"Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?","volume":"23","author":"Clausen","year":"2002","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/EJE-07-0386","article-title":"Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia","volume":"158","author":"Vatten","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semperi.2014.03.008_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/01443610802042852","article-title":"Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow","volume":"28","author":"Anastasakis","year":"2008","journal-title":"J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pd.973","article-title":"Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening","volume":"24","author":"Farina","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.semperi.2014.03.008_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1196\/annals.1318.015","article-title":"Fetal cell-free nucleic acids in the maternal circulation: new clinical applications","volume":"1022","author":"Wataganara","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.semperi.2014.03.008_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2012.09.006","article-title":"Cell-free fetal DNA and adverse outcome in low risk pregnancies","volume":"166","author":"Stein","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1053\/j.semperi.2014.03.008_bib51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"Chaiworapongsa","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"287","key":"10.1053\/j.semperi.2014.03.008_bib52","first-page":"e1","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib53","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"10.1053\/j.semperi.2014.03.008_bib54","first-page":"1742","article-title":"Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements","volume":"173","author":"Simpson","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"58","key":"10.1053\/j.semperi.2014.03.008_bib55","first-page":"e1","article-title":"First-trimester metabolomic detection of late-onset preeclampsia","volume":"208","author":"Bahado-Singh","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib56","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3109\/14767058.2012.680254","article-title":"Metabolomics and first-trimester prediction of early-onset preeclampsia","volume":"25","author":"Bahado-Singh","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib57","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1067\/mob.2002.127305","article-title":"The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature","volume":"187","author":"Brosens","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib58","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"Espinoza","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(83)91970-0","article-title":"New doppler technique for assessing uteroplacental blood flow","volume":"1","author":"Campbell","year":"1983","journal-title":"Lancet"},{"key":"10.1053\/j.semperi.2014.03.008_bib60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.0960-7692.2001.00572.x","article-title":"Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation","volume":"18","author":"Papageorghiou","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/jmf.12.2.78.88","article-title":"Second-trimester uterine artery Doppler screening in unselected populations: a review","volume":"12","author":"Papageorghiou","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib62","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.7863\/ultra.32.12.2107","article-title":"Third-trimester abnormal uterine artery Doppler findings are associated with adverse pregnancy outcomes","volume":"32","author":"Shwarzman","year":"2013","journal-title":"J Ultrasound Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.semperi.2008.04.019","article-title":"Monitoring of fetal well-being: role of uterine artery Doppler","volume":"32","author":"Ghidini","year":"2008","journal-title":"Semin Perinatol"},{"key":"10.1053\/j.semperi.2014.03.008_bib64","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.0960-7692.2001.00594.x","article-title":"Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11\u201314 weeks of gestation","volume":"18","author":"Martin","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11\u201341 weeks of gestation","volume":"32","author":"Gomez","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib66","article-title":"Uterine artery Doppler in the first trimester as a risk factor for adverse pregnancy outcomes: a meta-analysis involving 55,974 women","author":"Velauthar","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000341712","article-title":"Combined screening for preeclampsia and small for gestational age at 11\u201313 weeks","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1053\/j.semperi.2014.03.008_bib68","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajog.2012.01.022","article-title":"Doppler assessment of the fetus with intrauterine growth restriction","volume":"206","author":"Berkley","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.12371","article-title":"ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics","volume":"41","author":"Bhide","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007529.pub3","article-title":"Fetal and umbilical Doppler ultrasound in high-risk pregnancies","volume":"11","author":"Alfirevic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2014.03.008_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1471-0528.1985.tb01045.x","article-title":"Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation","volume":"92","author":"Giles","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0301-5629(85)90104-8","article-title":"Doppler ultrasound waveforms in the fetal umbilical artery: quantitative analysis technique","volume":"11","author":"Thompson","year":"1985","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.semperi.2014.03.008_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/uog.7724","article-title":"Abnormal brain microstructure and metabolism in small-for-gestational-age term fetuses with normal umbilical artery Doppler","volume":"36","author":"Sanz-Cortes","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejogrb.2007.02.016","article-title":"Small-for-gestational-age fetuses with normal umbilical artery Doppler have suboptimal perinatal and neurodevelopmental outcome","volume":"136","author":"Figueras","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1053\/j.semperi.2014.03.008_bib77","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1471-0528.2008.01670.x","article-title":"Predictiveness of antenatal umbilical artery Doppler for adverse pregnancy outcome in small-for-gestational-age babies according to customised birthweight centiles: population-based study","volume":"115","author":"Figueras","year":"2008","journal-title":"BJOG"},{"key":"10.1053\/j.semperi.2014.03.008_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1515\/JPM.2009.003","article-title":"Growth deficit in term small-for-gestational fetuses with normal umbilical artery Doppler is associated with adverse outcome","volume":"37","author":"Illa","year":"2009","journal-title":"J Perinat Med"},{"key":"10.1053\/j.semperi.2014.03.008_bib79","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1469-0705.1995.06040272.x","article-title":"Micro-bead embolization of uterine spiral arteries and changes in uterine arterial flow velocity waveforms in the pregnant ewe","volume":"6","author":"Ochi","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib80","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ajog.2004.09.019","article-title":"Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy","volume":"192","author":"Acharya","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib81","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/00016340600604757","article-title":"Variation in Doppler indices along the length of the cord from the intraabdominal to the placental insertion","volume":"85","author":"Khare","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1053\/j.semperi.2014.03.008_bib82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/uog.1902","article-title":"Reference ranges for serial measurements of blood velocity and pulsatility index at the intra-abdominal portion, and fetal and placental ends of the umbilical artery","volume":"26","author":"Acharya","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib83","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/humrep\/14.7.1890","article-title":"Prenatal assessment of the Hyrtl anastomosis and evaluation of its function: case report","volume":"14","author":"Raio","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1053\/j.semperi.2014.03.008_bib84","first-page":"1019","article-title":"Different umbilical artery flow velocity waveforms in one patient","volume":"71","author":"Trudinger","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib85","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-0528.1989.tb06312.x","article-title":"Discordant umbilical artery flow velocity waveforms and pregnancy outcome","volume":"96","author":"Harper","year":"1989","journal-title":"Br Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10354-012-0073-4","article-title":"MRI of the placenta\u2014a short review","volume":"162","author":"Dekan","year":"2012","journal-title":"Wien Med Wochenschr"},{"key":"10.1053\/j.semperi.2014.03.008_bib87","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/uog.8891","article-title":"Magnetic resonance imaging of the placenta identifies placental vascular abnormalities independently of Doppler ultrasound","volume":"37","author":"Messerschmidt","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.008_bib88","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejrad.2005.11.025","article-title":"Magnetic resonance imaging of the normal placenta","volume":"57","author":"Blaicher","year":"2006","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semperi.2014.03.008_bib89","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.placenta.2013.03.005","article-title":"Association of placental T2 relaxation times and uterine artery Doppler ultrasound measures of placental blood flow","volume":"34","author":"Derwig","year":"2013","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib90","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.placenta.2013.07.006","article-title":"Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome","volume":"34","author":"Derwig","year":"2013","journal-title":"Placenta"},{"key":"10.1053\/j.semperi.2014.03.008_bib91","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/jmri.22794","article-title":"Association of placental volume measured by MRI and birth weight percentile","volume":"34","author":"Derwig","year":"2011","journal-title":"J Magn Reson Imaging"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:56:32Z","timestamp":1538614592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000514000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0146000514000184"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2014.03.008","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second- and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2014.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}